Stocktoria
KORU Medical Systems, Inc. KRMD
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1993-10-27
KORU Medical Systems, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M | $17.4M | $12.3M | $12.2M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M | $14.9M | $14.9M | $10.8M | $7.6M | $7.6M |
| R&D expense | $4.4M | $5.3M | $5.7M | $5.0M | $2.5M | $1.3M | $740,475 | $241,124 | $237,486 | $207,282 |
| SG&A expense | $23.4M | $21.6M | $20.4M | $20.6M | $17.9M | $12.0M | $9.8M | $8.2M | $7.8M | $5.9M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M | -$1.3M | $585,679 | $1.2M | -$736,251 | $1.2M |
| Interest expense | — | — | — | — | — | — | — | — | $1,886 | $3,412 |
| Income tax | $21,890 | $2,893 | $4.0M | -$2.0M | -$1.8M | -$17,800 | $132,069 | $266,380 | -$241,700 | $359,706 |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M | -$4.6M | -$1.2M | $564,349 | $910,570 | -$534,999 | $782,864 |
| EPS (diluted) | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 | $0.01 | $0.02 | $-0.01 | $0.02 |
| Operating cash flow | $462,405 | -$319,718 | -$4.9M | -$5.4M | -$4.3M | -$743,323 | $320,620 | $1.5M | -$331,616 | $1.9M |
| Free cash flow | — | — | — | — | — | — | — | — | -$534,741 | $1.8M |
| Cash & equivalents | $8.9M | $9.6M | $11.5M | $17.4M | $25.3M | $27.3M | $5.9M | $3.7M | $3.3M | $4.2M |
| Inventory | $3.7M | $2.8M | $3.5M | $6.4M | $6.1M | $6.8M | $2.4M | $2.1M | $1.4M | $1.0M |
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M | $39.9M | $13.9M | $10.5M | $8.2M | $8.4M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M | $3.8M | $2.6M | $1.6M | $1.5M | $1.3M |
| Shareholders' equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M | $36.2M | $11.2M | $9.0M | $6.7M | $7.1M |
Growth · year-over-year · Revenue CAGR 14.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +22.2% | +18.0% | +2.2% | +18.8% | -2.8% | +4.4% | +33.5% | +41.2% | +0.4% | +8.9% |
| Net income growth | — | — | — | — | — | -314.8% | -38.0% | — | -168.3% | +3.9% |
| EPS growth | — | — | — | — | — | -400.0% | -50.0% | — | -150.0% | +0.0% |
| Free cash flow growth | — | — | — | — | — | — | — | — | -129.8% | +664.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.